Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Saint-Gobain Opens Life Sciences Lab in Mass. | Contract Pharma

What are you searching for?

Sign in
Breaking News

Saint-Gobain Opens Life Sciences Lab in Mass.

New lab is dedicated to application testing of single-use systems for the cell and gene therapy market

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Saint-Gobain Performance Plastics has opened a new life sciences laboratory on the campus of the University of Massachusetts Medical School in Worcester, MA, dedicated to application testing of single-use systems, with a focus on the cell and gene therapy market.

“We are very excited to have this new capability as we believe that it uniquely positions us to explore and examine the interface between materials and biology,” said Anne Hardy, vice president of R&D for Saint-Gobain’s high-performance materials sector. “Continuing to build this understanding is crucial to ensuring appropriate levels of material selection, modification and design in our products.”

Saint-Gobain designed its new facility to meet the highest quality and safety standards available to the industry. The Biosafety Level 2 lab enables the isolation, processing and culturing of primary and immortalized cells, and is equipped with high-end analytical equipment to observe and evaluate material, cell and protein interactions. A dedicated space for application development supports the advancement of new products with specific capabilities in sterile welding, pumping and low temperature testing.

“The Worcester lab is a critical component of our strategy to build upon our capabilities in the cell and gene therapy space,” said Steve Maddox, general manager, Saint-Gobain Life Sciences. “It allows us to more readily leverage our material science expertise to advance scalable, single-use solutions in bioprocessing.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics